Hyderabad-based water-tech company Althion has raised Rs 3.6 crore in a pre-Series A funding round. The investment was led by BioAngels, powered by the Indian Angel Network (IAN) Group, with notable participation from investors Arun Seth, Om Manchanda, KNK Venkatraman, and Shubham Rastogi. This new round adds to the company’s previous $180K funding from C-CAMP and other backers.
The company plans to use the funds to pilot the production of 40 units of its innovative tabletop laboratory water purification system. The investment will also support research and development (R&D) efforts for products aimed at improving the efficiency and sustainability of kidney dialysis. Additionally, Althion intends to establish a larger facility to scale its operations.
Founded in 2017 by Surya Rao, Althion specializes in creating ultra-pure water systems for the healthcare, research, and semiconductor industries. Its flagship innovations, aligned with India’s Make in India initiative, have found applications in dialysis centers, biotechnology labs, and hospitals across India. Althion’s solutions, including its proprietary Althion Remote Monitoring System (ARMS), offer predictive and preventive maintenance, enhancing the reliability and performance of their systems.
Althion’s products are trusted by leading institutions such as Sir Ganga Ram Hospital, Homi Bhabha Memorial Cancer Centre, Narayana Hrudayalaya, and Nephroplus centers. In addition to its product development efforts, the company has received grants from the Biotechnology Industry Research Assistance Council (BIRAC) to support the creation of its tabletop and dialysis products. It has also secured seed funding from C-CAMP Bangalore and AIC CCMB Hyderabad.
Looking ahead, Althion is on track to expand its global footprint with support for CE marking and USFDA certifications, paving the way for market access in regions including Latin America, Africa, and Asia. The company is poised to bridge the gap between high-cost water purification solutions and affordable, high-quality alternatives, helping to make healthcare and research more sustainable and efficient.
